Miltenyi Biotec acquires biosensor company lino Biotech

Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuri...

 March 27, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

 BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

 March 20, 2023 | News

Amgen and NSG Biolabs award first Golden Ticket in Singapore to Albatroz Therapeutics

Leading global biotechnology company Amgen and NSG BioLabs, Singapore's largest and leading provider of biotechnology (biotech) co-working labora...

 March 20, 2023 | News

Cytiva and TerraCycle expand first-of-its kind recycling program

Ryan Walker, Program Director, Sustainability, Cytiva, says: “The global expansion of our collaboration with TerraCycle demonstrates our commitment t...

 March 17, 2023 | News

China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval

On December 22, 2022, Likang submitted an IND application for LK101 Injection to NMPA, and received application shortly after. LK101 Injection, the fi...

 March 17, 2023 | News

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Ill...

 March 15, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

 March 14, 2023 | News

Leica Microsystems and Mentoring Hessen seal partnership

Leica Microsystems, a leader in microscopy and scientific instrumentation, has entered a partnership with Mentoring Hessen and strengthened its efforts to ...

 March 09, 2023 | News

Debiopharm Acquires Global Rights for Novo Nordisk's USP1 Inhibitor Development.

Debiopharm (, an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments to cure can...

 March 02, 2023 | News

GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, announced the expansion of its Singapor...

 March 01, 2023 | News

Merck Unveils Promising Four-Year Safety and Efficacy Data for Evobrutinib, Investigational BTK Inhibitor in RMS

Data from the ongoing Phase II extension showed treatment benefits of evobrutinib were maintained over four years and remained consistent with the effica...

 February 27, 2023 | News

Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio

Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development ...

 February 21, 2023 | News

Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease

Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...

 February 21, 2023 | News

"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"

According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...

 February 20, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in